ArticleBlood2024

In vivo ablation of NF-κB cascade effectors alleviates disease burden in myeloproliferative neoplasms.

Angelo B A Laranjeira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.